Evaluation of the thyroid and hypothyroid function after postoperative radiation therapy among breast cancer patients.
Rahimi N, Feizi I, Mashayekhi F, Salehi O, Norouzi F, Iranparvar-Alamdari M, Kani AA, Zandian H, Khalaji A.
Can Oncol Nurs J. 2024 Nov 1;34(4):477-489. doi: 10.5737/23688076344477. eCollection 2024 Fall.
Hypoparathyroidism after 131 I therapy.
Fulop M.
Ann Intern Med. 1971 Nov;75(5):808. doi: 10.7326/0003-4819-75-5-808_1.
The Effects of Radioiodine Therapy on the Recovery of Parathyroid Function in Patients with Protracted Hypoparathyroidism after Total Thyroidectomy for Papillary Thyroid Carcinoma.
Abuduwaili M, Baidula W, Xia B, Wu Z, Chen Z, Xing Z, Su A.
J Invest Surg. 2023 Dec 31;36(1):1-9. doi: 10.1080/08941939.2022.2146239. Epub 2022 Nov 21.
Hypoparathyroidism after I-131 therapy with subsequent return of parathyroid function.
Burch WM, Posillico JT.
J Clin Endocrinol Metab. 1983 Aug;57(2):398-401. doi: 10.1210/jcem-57-2-398.
Development of primary hypothyroidism with antithyroglobulin, antiperoxidase, and blocking-type thyrotropin receptor antibodies after radiation therapy for neuroblastoma.
Kikawa Y, Takeuchi M, Sudo M, Iida Y, Kasagi K, Konishi J.
J Pediatr. 1996 Dec;129(6):909-12. doi: 10.1016/s0022-3476(96)70037-9.
Health effects of therapeutic use of 131I in hyperthyroidism.
Pauwels EK, Smit JW, Slats A, Bourguignon M, Overbeek F.
Q J Nucl Med. 2000 Dec;44(4):333-9.
Pembrolizumab-Associated Hypoparathyroidism: A Single Case Report.
Mahmood I, Kuhadiya ND, Gonzalaes M.
AACE Clin Case Rep. 2020 Nov 28;7(1):23-25. doi: 10.1016/j.aace.2020.11.003. eCollection 2021 Jan-Feb.
[Definitive treatment of Graves' disease in children].
Ivannikova TE, Shiryaeva TY, Nagaeva EV, Sheremeta MS, Brovin DN, Bezlepkina OB.
Probl Endokrinol (Mosk). 2022 Apr 11;68(2):104-111. doi: 10.14341/probl13086.
Management of differentiated thyroid carcinomas.
Fernández-Vañes L, Llorente JL, García-Cabo P, Menéndez M, Pedregal D, Rodrigo JP, López F.
Acta Otorrinolaringol Esp (Engl Ed). 2019 Jul-Aug;70(4):200-206. doi: 10.1016/j.otorri.2018.03.002. Epub 2018 Jun 5.
Hypoparathyroidism after the treatment of laryngopharyngeal carcinoma.
Mortimore S, Thorp MA, Nilssen EL, Isaacs S.
J Laryngol Otol. 1998 Nov;112(11):1058-60. doi: 10.1017/s0022215100142458.
